Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chinyu Su

Showing results (11-20 of 65) with videos related to

Pageof 7
Sort By:
Journal of Crohn'S & Colitis|May 20, 2016
Direct and Indirect Effects of Tofacitinib on Treatment Satisfaction in Patients with Ulcerative ColitisJulian Panés, Chinyu Su, Andrew G Bushmakin, et al.
Gastroenterology|September 17, 2015
Correlation Between Concentrations of Fecal Calprotectin and Outcomes of Patients With Ulcerative Colitis in a Phase 2 TrialWilliam J Sandborn, Julian Panés, Haiying Zhang, et al.
Gastroenterology|May 8, 2004
A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn's diseaseChinyu Su, Gary R Lichtenstein, Karen Krok, et al.
Annals of the New York Academy of Sciences|July 13, 2006
The effect of anti-TNF-alpha therapy on spinal bone mineral density in patients with Crohn's diseaseMichael Pazianas, Andrew D Rhim, Andrew M Weinberg, et al.
BMC Gastroenterology|February 6, 2015
Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomesJulián Panés, Chinyu Su, Andrew G Bushmakin, et al.
The New England Journal of Medicine|August 17, 2012
Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitisWilliam J Sandborn, Subrata Ghosh, Julian Panes, et al.
Journal of Pain and Symptom Management|August 29, 2009
Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illnessBruce H Chamberlain, Karen Cross, Jaron L Winston, et al.
Clinical Pharmacology in Drug Development|May 13, 2022
Bridging Efficacy of Tofacitinib Immediate-Release to Extended-Release Formulations for Treatment of Ulcerative Colitis: Application of a Model-Informed Drug Development ApproachArnab Mukherjee, Shinichi Tsuchiwata, Cheng Chang, et al.
British Journal of Clinical Pharmacology|January 30, 2018
Exposure-response characterization of tofacitinib efficacy in moderate to severe ulcerative colitis: Results from a dose-ranging phase 2 trialArnab Mukherjee, Anasuya Hazra, Mike K Smith, et al.
Clinical Pharmacology in Drug Development|January 29, 2021
Population Pharmacokinetics of Tofacitinib in Patients With Moderate to Severe Ulcerative ColitisCamille Vong, Steven W Martin, Chenhui Deng, et al.
Pageof 7

Showing results (11-20 of 65) with videos related to

Sort By:
Pageof 7
Journal of Crohn'S & Colitis|May 20, 2016
Direct and Indirect Effects of Tofacitinib on Treatment Satisfaction in Patients with Ulcerative ColitisJulian Panés, Chinyu Su, Andrew G Bushmakin, et al.
Gastroenterology|September 17, 2015
Correlation Between Concentrations of Fecal Calprotectin and Outcomes of Patients With Ulcerative Colitis in a Phase 2 TrialWilliam J Sandborn, Julian Panés, Haiying Zhang, et al.
Gastroenterology|May 8, 2004
A meta-analysis of the placebo rates of remission and response in clinical trials of active Crohn's diseaseChinyu Su, Gary R Lichtenstein, Karen Krok, et al.
Annals of the New York Academy of Sciences|July 13, 2006
The effect of anti-TNF-alpha therapy on spinal bone mineral density in patients with Crohn's diseaseMichael Pazianas, Andrew D Rhim, Andrew M Weinberg, et al.
BMC Gastroenterology|February 6, 2015
Randomized trial of tofacitinib in active ulcerative colitis: analysis of efficacy based on patient-reported outcomesJulián Panés, Chinyu Su, Andrew G Bushmakin, et al.
The New England Journal of Medicine|August 17, 2012
Tofacitinib, an oral Janus kinase inhibitor, in active ulcerative colitisWilliam J Sandborn, Subrata Ghosh, Julian Panes, et al.
Journal of Pain and Symptom Management|August 29, 2009
Methylnaltrexone treatment of opioid-induced constipation in patients with advanced illnessBruce H Chamberlain, Karen Cross, Jaron L Winston, et al.
Clinical Pharmacology in Drug Development|May 13, 2022
Bridging Efficacy of Tofacitinib Immediate-Release to Extended-Release Formulations for Treatment of Ulcerative Colitis: Application of a Model-Informed Drug Development ApproachArnab Mukherjee, Shinichi Tsuchiwata, Cheng Chang, et al.
British Journal of Clinical Pharmacology|January 30, 2018
Exposure-response characterization of tofacitinib efficacy in moderate to severe ulcerative colitis: Results from a dose-ranging phase 2 trialArnab Mukherjee, Anasuya Hazra, Mike K Smith, et al.
Clinical Pharmacology in Drug Development|January 29, 2021
Population Pharmacokinetics of Tofacitinib in Patients With Moderate to Severe Ulcerative ColitisCamille Vong, Steven W Martin, Chenhui Deng, et al.
Pageof 7